Bococizumab is a cutting-edge anti-PCSK9 antibody efficiently developed to combat hypercholesterolemia. This therapeutic agent functions through the PCSK9 protein, a essential regulator of cholesterol levels. By https://www.targetmol.com/compound/bococizumab